Report Detail
Global Acute Ischemic Stroke Therapeutics Market Professional Survey Report 2019
- RnM3789792 |
- 27 September, 2019 |
- Global |
- 106 Pages |
- QYResearch |
- Pharma & Healthcare
AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics market is expected to register a low single digit market growth during the forecast period. The marginal growth rate is attributed to the lack of approved drugs in this area, the presence of alternative therapies, extensive use of generics, and unmet needs for anticoagulant reversal agents.
Technavio's analysts forecast the global acute ischemic stroke therapeutics market to grow at a CAGR of 2.11% during the period 2017-2025.
The global Acute Ischemic Stroke Therapeutics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of 0.021 during 2019-2025.
This report focuses on Acute Ischemic Stroke Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Acute Ischemic Stroke Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Acute Ischemic Stroke Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Acute Ischemic Stroke Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Bayer
Boehringer Ingelheim
Roche
Sanofi
Biogen
Daiichi Sankyo
Pfizer
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Thrombolytic Therapeutics
Antihypertensive Therapeutics
Antiplatelet Therapeutics
Anticoagulants
Segment by Application
Hospitals
Ambulatory Surgical Center
Diagnostic Centers
Table of Contents
Executive Summary
1 Industry Overview of Acute Ischemic Stroke Therapeutics
- 1.1 Definition of Acute Ischemic Stroke Therapeutics
- 1.2 Acute Ischemic Stroke Therapeutics Segment by Type
- 1.2.1 Global Acute Ischemic Stroke Therapeutics Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Thrombolytic Therapeutics
- 1.2.3 Antihypertensive Therapeutics
- 1.2.4 Antiplatelet Therapeutics
- 1.2.5 Anticoagulants
- 1.3 Acute Ischemic Stroke Therapeutics Segment by Applications
- 1.3.1 Global Acute Ischemic Stroke Therapeutics Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospitals
- 1.3.3 Ambulatory Surgical Center
- 1.3.4 Diagnostic Centers
- 1.4 Global Acute Ischemic Stroke Therapeutics Overall Market
- 1.4.1 Global Acute Ischemic Stroke Therapeutics Revenue (2014-2025)
- 1.4.2 Global Acute Ischemic Stroke Therapeutics Production (2014-2025)
- 1.4.3 North America Acute Ischemic Stroke Therapeutics Status and Prospect (2014-2025)
- 1.4.4 Europe Acute Ischemic Stroke Therapeutics Status and Prospect (2014-2025)
- 1.4.5 China Acute Ischemic Stroke Therapeutics Status and Prospect (2014-2025)
- 1.4.6 Japan Acute Ischemic Stroke Therapeutics Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Acute Ischemic Stroke Therapeutics Status and Prospect (2014-2025)
- 1.4.8 India Acute Ischemic Stroke Therapeutics Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Acute Ischemic Stroke Therapeutics
- 2.3 Manufacturing Process Analysis of Acute Ischemic Stroke Therapeutics
- 2.4 Industry Chain Structure of Acute Ischemic Stroke Therapeutics
3 Development and Manufacturing Plants Analysis of Acute Ischemic Stroke Therapeutics
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Acute Ischemic Stroke Therapeutics Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Acute Ischemic Stroke Therapeutics
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Acute Ischemic Stroke Therapeutics Production and Capacity Analysis
- 4.2 Acute Ischemic Stroke Therapeutics Revenue Analysis
- 4.3 Acute Ischemic Stroke Therapeutics Price Analysis
- 4.4 Market Concentration Degree
5 Acute Ischemic Stroke Therapeutics Regional Market Analysis
- 5.1 Acute Ischemic Stroke Therapeutics Production by Regions
- 5.1.1 Global Acute Ischemic Stroke Therapeutics Production by Regions
- 5.1.2 Global Acute Ischemic Stroke Therapeutics Revenue by Regions
- 5.2 Acute Ischemic Stroke Therapeutics Consumption by Regions
- 5.3 North America Acute Ischemic Stroke Therapeutics Market Analysis
- 5.3.1 North America Acute Ischemic Stroke Therapeutics Production
- 5.3.2 North America Acute Ischemic Stroke Therapeutics Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Acute Ischemic Stroke Therapeutics Import and Export
- 5.4 Europe Acute Ischemic Stroke Therapeutics Market Analysis
- 5.4.1 Europe Acute Ischemic Stroke Therapeutics Production
- 5.4.2 Europe Acute Ischemic Stroke Therapeutics Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Acute Ischemic Stroke Therapeutics Import and Export
- 5.5 China Acute Ischemic Stroke Therapeutics Market Analysis
- 5.5.1 China Acute Ischemic Stroke Therapeutics Production
- 5.5.2 China Acute Ischemic Stroke Therapeutics Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Acute Ischemic Stroke Therapeutics Import and Export
- 5.6 Japan Acute Ischemic Stroke Therapeutics Market Analysis
- 5.6.1 Japan Acute Ischemic Stroke Therapeutics Production
- 5.6.2 Japan Acute Ischemic Stroke Therapeutics Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Acute Ischemic Stroke Therapeutics Import and Export
- 5.7 Southeast Asia Acute Ischemic Stroke Therapeutics Market Analysis
- 5.7.1 Southeast Asia Acute Ischemic Stroke Therapeutics Production
- 5.7.2 Southeast Asia Acute Ischemic Stroke Therapeutics Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Acute Ischemic Stroke Therapeutics Import and Export
- 5.8 India Acute Ischemic Stroke Therapeutics Market Analysis
- 5.8.1 India Acute Ischemic Stroke Therapeutics Production
- 5.8.2 India Acute Ischemic Stroke Therapeutics Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Acute Ischemic Stroke Therapeutics Import and Export
6 Acute Ischemic Stroke Therapeutics Segment Market Analysis (by Type)
- 6.1 Global Acute Ischemic Stroke Therapeutics Production by Type
- 6.2 Global Acute Ischemic Stroke Therapeutics Revenue by Type
- 6.3 Acute Ischemic Stroke Therapeutics Price by Type
7 Acute Ischemic Stroke Therapeutics Segment Market Analysis (by Application)
- 7.1 Global Acute Ischemic Stroke Therapeutics Consumption by Application
- 7.2 Global Acute Ischemic Stroke Therapeutics Consumption Market Share by Application (2014-2019)
8 Acute Ischemic Stroke Therapeutics Major Manufacturers Analysis
- 8.1 Bayer
- 8.1.1 Bayer Acute Ischemic Stroke Therapeutics Production Sites and Area Served
- 8.1.2 Bayer Product Introduction, Application and Specification
- 8.1.3 Bayer Acute Ischemic Stroke Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Boehringer Ingelheim
- 8.2.1 Boehringer Ingelheim Acute Ischemic Stroke Therapeutics Production Sites and Area Served
- 8.2.2 Boehringer Ingelheim Product Introduction, Application and Specification
- 8.2.3 Boehringer Ingelheim Acute Ischemic Stroke Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Roche
- 8.3.1 Roche Acute Ischemic Stroke Therapeutics Production Sites and Area Served
- 8.3.2 Roche Product Introduction, Application and Specification
- 8.3.3 Roche Acute Ischemic Stroke Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Sanofi
- 8.4.1 Sanofi Acute Ischemic Stroke Therapeutics Production Sites and Area Served
- 8.4.2 Sanofi Product Introduction, Application and Specification
- 8.4.3 Sanofi Acute Ischemic Stroke Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Biogen
- 8.5.1 Biogen Acute Ischemic Stroke Therapeutics Production Sites and Area Served
- 8.5.2 Biogen Product Introduction, Application and Specification
- 8.5.3 Biogen Acute Ischemic Stroke Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Daiichi Sankyo
- 8.6.1 Daiichi Sankyo Acute Ischemic Stroke Therapeutics Production Sites and Area Served
- 8.6.2 Daiichi Sankyo Product Introduction, Application and Specification
- 8.6.3 Daiichi Sankyo Acute Ischemic Stroke Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Pfizer
- 8.7.1 Pfizer Acute Ischemic Stroke Therapeutics Production Sites and Area Served
- 8.7.2 Pfizer Product Introduction, Application and Specification
- 8.7.3 Pfizer Acute Ischemic Stroke Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
9 Development Trend of Analysis of Acute Ischemic Stroke Therapeutics Market
- 9.1 Global Acute Ischemic Stroke Therapeutics Market Trend Analysis
- 9.1.1 Global Acute Ischemic Stroke Therapeutics Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Acute Ischemic Stroke Therapeutics Regional Market Trend
- 9.2.1 North America Acute Ischemic Stroke Therapeutics Forecast 2019-2025
- 9.2.2 Europe Acute Ischemic Stroke Therapeutics Forecast 2019-2025
- 9.2.3 China Acute Ischemic Stroke Therapeutics Forecast 2019-2025
- 9.2.4 Japan Acute Ischemic Stroke Therapeutics Forecast 2019-2025
- 9.2.5 Southeast Asia Acute Ischemic Stroke Therapeutics Forecast 2019-2025
- 9.2.6 India Acute Ischemic Stroke Therapeutics Forecast 2019-2025
- 9.3 Acute Ischemic Stroke Therapeutics Market Trend (Product Type)
- 9.4 Acute Ischemic Stroke Therapeutics Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Acute Ischemic Stroke Therapeutics Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Acute Ischemic Stroke Therapeutics. Industry analysis & Market Report on Acute Ischemic Stroke Therapeutics is a syndicated market report, published as Global Acute Ischemic Stroke Therapeutics Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Acute Ischemic Stroke Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
